-
Main ProductsThe company regards product quality as the life of the enterprise, and strictly implements quality management. Professional testing and testing instrument are equipped. Sterile products are produced in a 100,000 Class clean workshop with a purification area of nearly 3,600 m² to ensure that the products meet the hygiene requirements.
-
Scientific ResearchThe present factory covers an area of nearly 83,000 square meters, and has a 100,000 Class clean workshop, warehouse and standard testing room built according to the YY0033-2000 standard. The purification area is 22,000 square meters. Among them, the testing room covers an area of about 1,200 square meters, equipped with a 10,000 Class sterile testing room, a positive testing room and a microbial limit testing room.
-
Service & SupportReborn Medical continues to introduce high-end technical talents such as masters and doctors. It has more than 300 staff now, including 60 R&D personnel. The company has established collaborative research projects with national universities and hospitals including Hunan University, Xiangtan University, Hunan University of Technology, and The First Affiliated Hospital of Guangzhou Medical University through industry-academia-research partnerships. The company spends 12% of its annual sales on research and development for product upgrades and new product development.
-
About RebornRuibang Medical is a high-tech enterprise specializing in the research and development, production, and sales of medical devices, and is committed to promoting and selling international advanced medical products and medical technology markets.
-
Updated NewsAs a high-end consumables manufacturing enterprise in urology, Ruibang Medical has 42 product registration certificates, 12 products have obtained EU CE certification, 37 patents, 6 authorized invention patents, and 7 audited invention patents.
-
Contact UsThe company is committed to market cultivation and construction, rooted in the concept of honest service in the market. Its market service institutions cover 31 provinces, municipalities, and autonomous regions across the country, forming a tiered network for sales. Its products have been sold to 26 countries overseas.
Investigate the effects of Discharged Patients with Indwelling Double J Ureteral Stent by Different Follow-up Methods
Apr 25,2022
Recently, doctors from the Department of Urology at Guilin Medical University Affiliated Hospital, including Quan Xiangfeng, Jing Ji, and Lu Suqing, published a paper aiming to collect the information about the effectiveness of post-discharge health via telephone, email, and QQ follow-ups for patients with indwelling double-J ureteral stent. The study concluded that providing multiple follow-up options allows patients to choose based on their circumstances. Extending hospital-based health education to patients’ homes reduced complications, achieved positive social outcomes, and received high praise from patients and their families. The paper was published in Chinese Journal of Practical Nursing, Volume 27, Issue 5, 2011.
A total of 319 patients with indwelling double-J stent were randomly dividedinto four groups: a control group (88 patients), a telephone follow-up group (89 patients), an email follow-up group (70 patients), and a QQ follow-up group (72 patients). All groups received routine health education during hospitalization and before discharge. Post-discharge, doctors conducted follow-ups via telephone, email, or QQ for the respective groups to observe rehabilitation outcomes.
The telephone, email, and QQ groups exhibited significantly fewer complications during stent placement and demonstrated significantly better knowledge of complication prevention and management compared to the control group.
Related News
2025-11-06
Expo Med Hospitalar 2025(Mexico)
2025-11-06
2025UAA（Bali Island of Indonesia)
2025-11-06
2025-05-09
2025-05-09
Address
Building B8 and B9 No.959,Tianyi Great Road Xinmajingu Industrial Zone Gaoxin District 412000 Zhuzhou City,Hunan Province PEOPLE'S REPUBLIC OF CHINA